Looking back to 72 days ago, Vanda Pharmaceuticals Inc (Symbol: VNDA) priced a 5,000,000 share secondary stock offering at $11.60 per share. Buyers in that offering made a considerable investment into the company, expecting that …
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)’s shares have advanced by more than 9% after the U.S. Food and Drug Administration approved Vanda’s supplemental New Drug Application for expanding the prescribing information to …
I read this article and found it very interesting, thought it might be interesting for you. The article is called Will H.C. …
WASHINGTON, July 21, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced …
Bllionaire hedge fund magnate John Paulson bought into the biopharmaceutical company at the start of the year and as of the third quarter holds 3.25 million VNDA shares. The stock has gained +12.13% year-to-date. Receptos Inc …
Vanda Pharmaceuticals, Inc. engages in the research, development, and commercialization of biopharmaceutical products. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian …
Venbio Select Advisor Llc sold 446,227 shares as Vanda Pharmaceuticals Inc (VNDA)’s stock declined 5.00%. The …
Given that liquidity is king in short-term, SPPI is a stock with 79.92 million shares outstanding that normally trades 10.49% of its float. It has outperformed by 34.90% the S&P500. We have $15.78 PT which if reached, will make …
The stock decreased 0.63% or ... Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) to report earnings on July, 26. Renaissance Techs Lc has 568,350 shares. Kingdon Mngmt Ltd Com holds 0.32% in Vanda Pharmaceuticals Inc.